Abstract:Deviation in level of intrinsic neural activity (ongoing brain signals recorded with EEG/MEG) is observed in psychosis. Neurophysiological models have proposed this physiological indicator as a genetically mediated core deviation in psychosis. Translational models of intrinsic activity deviations promise to identifying multiple distinct physiological mechanisms for psychosis manifestation. Intrinsic activity deviations may masquerade as higher levels of neural response in sensory cortices, but ultimately may lead to poor signal-to-noise ratios, particularly when psychosis cases are required to identify stimulus salience. Why do we not hear more about intrinsic activity as a core biomarker for any psychosis variation? An explanation is provided by the current project. The Bipolar-Schizophrenia Network for Intermediate Phenotypes (B-SNIP) published a means for categorizing psychoses by neurobiological homology via use of multiple biomarkers (psychosis Biotypes) rather than by clinical features. B-SNIP demonstrated the superiority of Biotypes versus DSM diagnoses for capturing neurobiological similarity through multiple external validating measures (social functioning, measures of brain volume from structural magnetic resonance images, clinical diagnoses and biomarker features among first-degree relatives). Independent analyses since the initial publication have provided additional support for the usefulness of psychosis Biotypes. For this project, we analyzed ongoing neural activity from 64 EEG sensors during 150 intervals of 10 sec duration from over 1450 B-SNIP subjects. These data (never before published) were from the inter-trial interval (ITI) of an auditory paired-stimuli task used in Biotypes construction (these ITI data themselves were not used). Although the subjects were engaged in a task (counting the number of stimulus pairs), the data used here were not part of the task itself. Data were evaluated for single trial power (estimate of neural response strength on individual trials) as a function of frequency of neural oscillations (from 2–50 Hz) over the whole head. Data were then averaged over single trials to yield an estimate of the overall strength of nonspecific (unrelated to sensory processing) neural activity. When evaluated by DSM diagnoses (schizophrenia, schizoaffective disorder, bipolar disorder), the 95% confidence intervals for all groups overlapped the healthy group means across all frequencies. When considered by psychosis Biotypes, differences were obvious and statistically significant. In comparison to healthy persons, Biotype-2 probands (the most neurophysiologically activated subgroup in previous analyses) were notably high on nonspecific neural activity, and Biotype-1 probands (the most cognitively and neurophysiologically compromised subgroup in previous analysis) were notably low. Group separations on this metric were better than those obtained with original intrinsic EEG measure used in psychosis Biotypes construction, indicating this more pure intrinsic activity measure is capturing a meaningful component of Biotype neurophysiology. This was true across a range of oscillatory frequencies for the probands. The first-degree relatives of the Biotype probands showed similar patterns, although higher frequency oscillations (above 20 Hz) better differentiated relatives from healthy persons. Intrinsic activity deviation is a promising biomarker for translational research programs aimed at differential treatment development, but using DSM psychosis diagnoses would obscure its importance for understanding psychosis.

Characterizing Functional Regional Homogeneity (reho) As a B-SNIP Psychosis Biomarker Using Traditional and Machine Learning Approaches.

Distinguishing Hypochondriasis and Schizophrenia Using Regional Homogeneity: a Resting-State Fmri Study and Support Vector Machine Analysis.

Regional homogeneity and functional connectivity analysis of resting-state magnetic resonance in patients with bipolar II disorder.

Supervised Machine Learning Classification of Psychosis Biotypes Based on Brain Structure: Findings from the Bipolar-Schizophrenia Network for Intermediate Phenotypes (B-SNIP).

Abnormal regional homogeneity as potential imaging biomarker for psychosis risk syndrome: a resting-state fMRI study and support vector machine analysis

147. Resting State Connectivity in Traditional and Biologically Derived B-SNIP Psychosis Subtypes

The abnormalities of regional homogeneity in the resting-state of first-episode medication-na(i)ve schizophrenia

Examining Functional Resting-State Connectivity in Psychosis and Its Subgroups in the Bipolar-Schizophrenia Network on Intermediate Phenotypes Cohort

Primary Study of Resting State Functional Magnetic Resonance Imaging in Early Onset Schizophrenia Using ReHo

Diagnostic value of regional homogeneity and fractional amplitude of low-frequency fluctuations in the classification of schizophrenia and bipolar disorders

Evaluation of boundaries between mood and psychosis disorder using dynamic functional network connectivity (dFNC) via deep learning classification

Deviant spontaneous neural activity as a potential early-response predictor for therapeutic interventions in patients with schizophrenia

M61. Data-Driven Approach Identified Functionally and Physiologically Distinct Psychosis Subtypes

Differentiating Biomarker Features and Familial Characteristics of B-SNIP Psychosis Biotypes

Psychosis Biotypes: Replication and Validation from the B-SNIP Consortium.

O3.1. NEUROTYPING UNTREATED FIRST EPISODE SCHIZOPHRENIA ON THE BASIS OF SLOW-WAVE RESTING-STATE DYNAMICS

Regional Homogeneity of the Left Posterior Cingulate Gyrus May Be a Potential Imaging Biomarker of Manic Episodes in First-Episode, Drug-Naive Bipolar Disorder

Abnormal Regional Homogeneity As a Potential Imaging Biomarker for Adolescent-Onset Schizophrenia: A Resting-State Fmri Study and Support Vector Machine Analysis

9.3 PSYCHOSIS BIOTYPES VERSUS CLINICAL SYNDROMES THROUGH THE PRISM OF INTRINSIC NEURAL ACTIVITY

Identification of Distinct Psychosis Biotypes Using Brain-Based Biomarkers

Neurobiology-based Cognitive Biotypes Using Multi-scale Intrinsic Connectivity Networks in Psychotic Disorders